FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > HUGE Reset

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Oct 02, 2021 11:01pm

44 Views

Post# 33958241

RE:HUGE Reset

Through further dilution of shares on the backs of investors.....their next step was for the CEO, AD, to hire 6 marketing firms at a cost of $2.5M annually plus 219936 shares to hype FSD with nothing to hype......now they have to hire an entire team to even think of beginning any development let alone trials........why aren't you adding this info Rosenberg......it's is relevant and actually factual.....